Company / Tangible Book Value per Share
ARS Pharmaceuticals, Inc. Tangible Book Value per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$1.17
FY2025
5-year range
-$1.08 / $2.66
FY2021-FY2025
Trend
-56.2%
vs FY2024
Sector context
#155 of 209
Health Care
What the data says
At $1.17, ARS Pharmaceuticals, Inc.'s tangible book value per share ranks #155 of 209 in the Health Care sector. Declined from $2.46 to $1.17 over the past 2 years.
Based on SEC 10-K filings.
1.17 in FY2025.
Declined from $2.46 to $1.17 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#155 of 209 in Health CareTop 74% of 209This company $1.17 Sector average $93.47
▼
-98.8% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share decreased 56.2% year-over-year.
- Ranks #155 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2024.
- Lowest tangible book value per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.17 | -56.2% |
| FY2024 | $2.66 | +8.4% |
| FY2023 | $2.46 | +338.6% |
| FY2022 | -$1.03 | +4.9% |
| FY2021 | -$1.08 | +77.6% |
| FY2020 | -$4.83 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026